Fanconi anemia, put to sleep
Andrew J Deans
BLOOD | AMER SOC HEMATOLOGY | Published : 2021
In this issue of Blood, Okamoto et al describe how reduced levels of Schlafen protein SLFN11 can rescue the DNA damage sensitivity in a Fanconi anemia (FA) cell line. They propose SLFN11 as a potential target for treatment of FA.